Publications analysis of major medical institutions in China indexed in PubMed from 2019 to 2021
10.3760/cma.j.cn113565-20220228-00027
- VernacularTitle:2019—2021年国内主要医疗机构在PubMed发表论文情况分析
- Author:
Shuxia SHI
1
;
Hua YANG
Author Information
1. 中国医科大学附属盛京医院图书馆，沈阳 110004
- Keywords:
Medical institutes;
Scientific research evaluation;
Publications;
PubMed
- From:
Chinese Journal of Medical Science Research Management
2022;35(3):197-204
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To understand the development trend of scientific research in major medical institutions in China from 2019 to 2021.Methods:The PubMedplus database was searched, and the distribution of papers, published journals and its′ influencing factors (IF) of top 30 domestic medical institutions from 2019 to 2021 were statistically analyzed.Results:From 2019 to 2021, 84 405 PubMed papers were published by the top 30 medical institutions, including 79 459 papers in English, accounted for 94.14%, and 4 946 papers in Chinese, accounted for 5.86%. Of them, 22 447, 29 540 and 32 430 papers were published in 2019, 2020 and 2021. 75 240 papers in English were indexed by SCI database (89.14% of total English papers). 17 729 papers (accounted for 21.00%) were published by the top 27 journals, Frontier in Oncology ranks first. 4 400 papers (5.85% of total) were published by the journals of impact factors greater than 10. The biggest portion of the papers, 26 550 papers (35.29% of total) were published by the journals of impactor factor from 3 to 5. Conclusions:The quantity and quality of papers published by major medical institutions in China have been greatly improved each year. The progress level of medical institutions is different, and their advantageous disciplines of medical institutions have been well reflected.
